Current
19.4×
5-Year Average
20.3×
All-Time High
39.7×
All-Time Low
7.3×
EV/EBITDA daily chart for Thermo Fisher Scientific (TMO)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical EV/EBITDA for Thermo Fisher Scientific (TMO) from 2001 to 2025
| 2025 | $217.87B | $11.48B | 21.7× | +2.4× | |
| 2024 | $199.17B | $11.74B | 19.3× | -1.6× | |
| 2023 | $205.42B | $11.17B | 20.9× | +0.6× | |
| 2022 | $215.32B | $11.94B | 20.3× | -4.3× | |
| 2021 | $262.89B | $11.96B | 24.6× | +5.1× | |
| 2020 | $184.91B | $10.11B | 19.5× | -1.2× | |
| 2019 | $129.62B | $7.02B | 20.7× | +3.5× | |
| 2018 | $89.96B | $6.20B | 17.2× | -1.7× | |
| 2017 | $76.14B | $5.05B | 19.0× | +2.6× | |
| 2016 | $55.68B | $4.38B | 16.3× | -0.7× | |
| 2015 | $56.67B | $4.04B | 17.0× | +1.1× | |
| 2014 | $49.84B | $3.97B | 15.9× | -1.2× | |
| 2013 | $40.29B | $2.63B | 17.1× | +5.4× | |
| 2012 | $22.84B | $2.49B | 11.7× | +1.1× | |
| 2011 | $16.79B | $2.16B | 10.5× | -1.0× | |
| 2010 | $21.51B | $1.96B | 11.6× | +0.6× | |
| 2009 | $19.53B | $1.83B | 11.0× | +3.7× | |
| 2008 | $14.23B | $2.05B | 7.3× | -7.2× | |
| 2007 | $24.08B | $1.77B | 14.5× | -25.3× | |
| 2006 | $19.03B | $528.40M | 39.7× | +26.8× | |
| 2005 | $4.91B | $403.57M | 12.9× | -1.4× | |
| 2004 | $4.86B | $319.48M | 14.4× | -0.2× | |
| 2003 | $4.16B | $276.65M | 14.5× | +0.8× | |
| 2002 | $3.28B | $243.58M | 13.7× | -2.8× | |
| 2001 | $4.16B | $265.43M | 16.5× | — |
- 202521.7×
- 202419.3×
- 202320.9×
- 202220.3×
- 202124.6×
- 202019.5×
- 201920.7×
- 201817.2×
- 201719.0×
- 201616.3×
- 201517.0×
- 201415.9×
- 201317.1×
- 201211.7×
- 201110.5×
- 201011.6×
- 200911.0×
- 20087.3×
- 200714.5×
- 200639.7×
- 200512.9×
- 200414.4×
- 200314.5×
- 200213.7×
- 200116.5×
About EV/EBITDA at Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific (TMO) EV/EBITDA ratio is 19.4× as of June 5, 2026. The 5-year average is 20.3×. The sector median currently stands at 15.0×. The current ratio is at the 29th percentile of its own 10-year history.
Thermo Fisher Scientific (TMO) historical EV/EBITDA ratio has ranged from a low of 7.3× (2008) to a high of 39.7× (2006) in the available daily series.
The EV/EBITDA ratio (the enterprise multiple) compares enterprise value (EV) to trailing twelve-month (TTM) EBITDA. EV is calculated as market capitalisation + total debt − cash & short-term investments. Because EV/EBITDA is capital-structure-neutral and ignores non-cash depreciation and amortisation, it is the standard multiple used in M&A and for cross-company or cross-border comparisons. Note: this calculation uses a simplified EV (minority interest and preferred equity excluded due to data availability), consistent with most public financial-data providers.
Thermo Fisher Scientific EV/EBITDA by Year
Thermo Fisher Scientific EV/EBITDA 2025: 21.7×
Thermo Fisher Scientific (TMO) EV/EBITDA ratio in 2025 was 21.7×, expanded from 19.3× the prior year.
Thermo Fisher Scientific EV/EBITDA 2024: 19.3×
Thermo Fisher Scientific (TMO) EV/EBITDA ratio in 2024 was 19.3×, contracted from 20.9× the prior year.
Thermo Fisher Scientific EV/EBITDA 2023: 20.9×
Thermo Fisher Scientific (TMO) EV/EBITDA ratio in 2023 was 20.9×, expanded from 20.3× the prior year.
Thermo Fisher Scientific EV/EBITDA 2022: 20.3×
Thermo Fisher Scientific (TMO) EV/EBITDA ratio in 2022 was 20.3×, contracted from 24.6× the prior year.
Thermo Fisher Scientific EV/EBITDA 2021: 24.6×
Thermo Fisher Scientific (TMO) EV/EBITDA ratio in 2021 was 24.6×.
EV is calculated as Market Cap + Total Debt − Cash & Short-Term Investments (simplified). Minority interest and preferred equity are excluded due to data availability. This is consistent with the methodology used by most public financial data providers.
Sector peers by EV/EBITDA — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by EV/EBITDA — table
Healthcare peers of Thermo Fisher Scientific (TMO), ranked by EV/EBITDA ratio.
| 13.9× | |
| 13.6× | |
| 13.6× | |
| 13.2× | |
| 12.9× | |
| 12.9× | |
| 12.7× | |
| 12.4× | |
| 12.0× | |
| 11.7× | |
| 11.5× | |
| 11.5× | |
| 11.2× | |
| 10.5× | |
| 10.0× | |
| 8.8× | |
| 8.5× | |
| 8.2× | |
| 7.9× | |
| 7.8× | |
| 6.8× | |
| 6.5× | |
| 5.8× | |
| 5.7× | |
| 4.5× |
- 13.6×
- 13.2×
- 12.9×
- 12.4×
- 12.0×
- 11.7×
- 11.5×
- 10.5×
- 10.0×
- 8.5×
- 8.2×
- 7.9×
- 7.8×
- 5.8×
- 4.5×
Frequently asked questions
Thermo Fisher Scientific (TMO) Key Financials
Charts, filings, and peer comparison for every metric